Inhalation device

- Glaxo Group Limited
Description

FIG. 1 is a top plan view of the inhalation device showing my new design;

FIG. 2 is a bottom plan view thereof;

FIG. 3 is a front perspective view showing the top and left side thereof;

FIG. 4 is a side elevational view showing the left side thereof;

FIG. 5 is a side elevational view showing the right side thereof;

FIG. 6 is a front view thereof;

FIG. 7 is a rear elevational view thereof;

FIG. 8 is a top plan view thereof with the mouthpiece cover removed;

FIG. 9 is a front perspective view showing the top and left side thereof with the mouthpiece cover removed;

FIG. 10 is a side elevational view showing the left side thereof with the mouthpiece cover removed;

FIG. 11 is a side elevational view showing the right side thereof with the mouthpiece cover removed; and,

FIG. 12 is a front view thereof with the mouthpiece cover removed.

Referenced Cited
U.S. Patent Documents
D342994 January 4, 1994 Rand et al.
D355029 January 31, 1995 Kinneir et al.
4834083 May 30, 1989 Byram et al.
5035237 July 30, 1991 Newell et al.
Patent History
Patent number: D391369
Type: Grant
Filed: Oct 10, 1996
Date of Patent: Feb 24, 1998
Assignee: Glaxo Group Limited (London)
Inventor: Gregor John McLennan Anderson (Ware)
Primary Examiner: Stella Reid
Law Firm: Bacon & Thomas
Application Number: 0/60,921
Classifications
Current U.S. Class: Respirator, Vaporizer, Or Inhalation Tube (4) (D24/110)
International Classification: 2404;